In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Alkermes acquires Reliant in tax-free stock swap; withdrawn

Executive Summary

Alkermes (drug delivery) will acquire Reliant Pharmaceuticals in a tax-free stock swap, giving Reliant 31.07mm Alkermes common shares, or about a 31% stake in the combined company. The deal is worth approximately $894.5mm based on Alkermes' pre-announcement average share price.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Withdrawn
Deal Type
  • Acquisition
    • Includes Contract
    • Partial Acquisition
    • Payment Includes Stock

Related Companies